Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131677
Status:
COMPLETED
Last Update Posted:
2014-03-10
First Post:
2005-08-17
Brief Title:
Extended Safety Study of Tenofovir Disoproxil Fumarate TDF Among HIV-1 Negative Men
Sponsor:
Centers for Disease Control and Prevention
Organization:
Centers for Disease Control and Prevention
Study Overview
Official Title:
Phase II Extended Safety Study of Tenofovir Disoproxil Fumarate TDF Among HIV-1 Negative Men
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine safety and tolerability of daily tenofovir use in HIV-uninfected men
Detailed Description:
This study will assess the clinical and behavioral safety and tolerability of oral daily TDF use as pre-exposure prophylaxis PrEP to prevent HIV infection in uninfected men
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None